This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2025 Aug 21;146(8):903-905.

doi: 10.1182/blood.2025029271.

Protecting the epithelium and taming GVHD

Yishan Ye^{1

2}, Mohamad Mohty¹

Affiliations

PMID: 40839253
DOI: 10.1182/blood.2025029271

Editorial

Protecting the epithelium and taming GVHD

Yishan Ye et al. Blood. 2025.

. 2025 Aug 21;146(8):903-905.

doi: 10.1182/blood.2025029271.

Authors

Yishan Ye^{1

2}, Mohamad Mohty¹

Affiliations

¹ Sorbonne Université.
² The First Affiliated Hospital of Zhejiang University School of Medicine.

PMID: 40839253
DOI: 10.1182/blood.2025029271

No abstract available

PubMed Disclaimer

Comment on

Phase 1/2 study of high-dose palifermin for GVHD prophylaxis in patients undergoing HLA-matched unrelated donor HCT.
Schulz E, Curtis LM, Holtzman NG, Steinberg SM, Wloka K, Ostojic A, Mina A, El Jurdi N, Pirsl F, Carpenter A, Golagha M, Sirajuddin A, Heller T, Shaffer BC, Hakim FT, Rubin JS, Gress RE, Pavletic SZ. Schulz E, et al. Blood. 2025 Aug 21;146(8):944-950. doi: 10.1182/blood.2024028303. Blood. 2025. PMID: 40331908 Clinical Trial.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems